Biopharmaceutical drug company venture financing witnessed a downturn in Q1 2025 —a 20.2% decline from the $8.1bn raised in ...

Boehringer Ingelheim, along with the University of Oxford, UK, and Cumulus Neuroscience, has launched a study for BPD.

The astronomical rise in popularity of GLP-1RAs in recent years has led to a shortage, prompting users to turn to compounders ...

When Donald Trump descended a golden escalator at Trump Tower in New York City in 2015 to announce the launch of his first ...

Abeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease ...

The FDA has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA).

MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.

The FDA approved AstraZeneca's Truqap in November 2023 for the treatment of advanced HR-positive breast cancer.

US President Donald Trump mentioned the possibility of potential tariffs on foreign-made pharmaceuticals. This threat was ...

While the pharmaceutical industry is currently exempt from US tariffs, there is an increased risk to the stability of the ...

CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.

While pharma manufacturing deals in the US increased, large cuts to research and regulatory agencies increased concerns for the sector.